These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10974382)

  • 1. A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer.
    Hayter CR; Huff-Winters C; Paszat L; Youssef YM; Shelley WE; Schulze K
    Radiother Oncol; 2000 Sep; 56(3):329-33. PubMed ID: 10974382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
    Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
    Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial.
    Borg D; Sundberg J; Brun E; Kjellén E; Petersson K; Hermansson M; Johansson J; Eberhard J; Johnsson A
    Acta Oncol; 2020 Feb; 59(2):212-218. PubMed ID: 31564184
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
    Coia LR; Engstrom PF; Paul A
    J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus.
    Harney J; Goodchild K; Phillips H; Glynne-Jones R; Hoskin PJ; Saunders MI
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):109-14. PubMed ID: 12801046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia.
    Harvey JA; Bessell JR; Beller E; Thomas J; Gotley DC; Burmeister BH; Walpole ET; Thomson DB; Martin I; Doyle L; Burmeister E; Smithers BM
    Dis Esophagus; 2004; 17(3):260-5. PubMed ID: 15361102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus.
    Powell ME; Hoskin PJ; Saunders MI; Foy CJ; Dische S
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):133-6. PubMed ID: 9212014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia.
    Kawamoto T; Nihei K; Sasai K; Karasawa K
    Int J Clin Oncol; 2018 Dec; 23(6):1076-1083. PubMed ID: 30066207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
    Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
    Bhatt L; Tirmazy S; Sothi S
    Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
    Algan O; Coia LR; Keller SM; Engstrom PF; Weiner LM; Schultheiss TE; Hanks GE
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):753-61. PubMed ID: 7790262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction.
    Coia LR; Paul AR; Engstrom PF
    Cancer; 1988 Feb; 61(4):643-9. PubMed ID: 3338031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
    Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
    Sunde B; Ericson J; Kumagai K; Lundell L; Tsai JA; Lindblad M; Rouvelas I; Friesland S; Wang N; Nilsson M
    Dis Esophagus; 2016 Jul; 29(5):442-7. PubMed ID: 25809837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
    Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study.
    John M; Flam M; Wittlinger P; Mowry PA
    Am J Clin Oncol; 1987 Aug; 10(4):310-6. PubMed ID: 2441591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
    Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
    Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.